DMK
SEEL

David M. Knott’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

David M. Knott’s Portfolio SEEL Stock Details SEEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$174K Hold
19
– – 0.06% 100
2021
Q2 		$191K Hold
19
– – 0.07% 100
2021
Q1 		$361K Buy
+19
New +$222K 0.15% 73

Other funds holding SEEL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
GJL
Gendell Jeffrey L $11.3B AUM 163.05% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $1.07B AUM 34.04% 1-Year Est. Return

David M. Knott's SEEL Position: Q3 2021 in Review

David M. Knott held its Seelos Therapeutics, Inc. Common Stock (SEEL) position steady in Q3 2021 at 19 shares worth $174K. The position accounts for 0.06% of the portfolio, ranked #100.

David M. Knott first reported a position in SEEL in Q1 2021 and has held it in 3 quarters since. The position peaked at $361K in Q1 2021. 95 funds tracked by Wall St. Rank hold SEEL as of Q3 2021.

  • David M. Knott held 19 shares of Seelos Therapeutics, Inc. Common Stock worth $174K as of Q3 2021.
  • David M. Knott left its Seelos Therapeutics, Inc. Common Stock share count unchanged in Q3 2021.
  • Seelos Therapeutics, Inc. Common Stock made up 0.06% of David M. Knott's portfolio in Q3 2021, its #100 holding.
  • David M. Knott first reported a position in Seelos Therapeutics, Inc. Common Stock in Q1 2021 and has held it in 3 quarters since.
  • David M. Knott's Seelos Therapeutics, Inc. Common Stock position peaked at $361K in Q1 2021.
  • 95 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q3 2021.

Based on David M. Knott's 13F filing for Q3 2021, filed 12 Nov 2021.